Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
Source:
bloombergMarkets
June 8, 2026 · 08:09
On this episode of Stock Movers with Alexis Christoforous:
- Shares of The Campbell's Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate.
- Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company’s incretin portfolio is “not built around singular blockbusters.”
- Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell’s in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement. (S…
The original article opens on the publisher's website.
More from Economy
View topic →China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says
cnbc
Sep 1, 2026 · 16:52
US diesel prices soar as Trump hauls in refiners
financialTimes
Sep 1, 2026 · 14:18
Anthropic's Claude Fable 5.1 and Mythos 5.1 arrive with a 75% cost reduction for Fable cache reads
ventureBeat
Sep 1, 2026 · 11:41
Prediction market traders think job creation rebounded in August
cnbc
Sep 1, 2026 · 11:16
Your files stay put: Perplexity’s hybrid AI keeps confidential data off the cloud
ventureBeat
Sep 1, 2026 · 08:00
Countries mentioned